Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, Peter G., Kauffman, Carol A., Andes, David, Benjamin, Daniel K., Calandra, Thierry F., Edwards, John E., Filler, Scott G., Fisher, John F. +6 more·2009·Clinical Infectious Diseases

Cited by (1,018)

Items 801–900 of 1,018

  1. Fungicidal versus fungistatic therapy of invasive Candida infection in non-neutropenic adults: a meta-analysis
    Anand Kumar, Ryan Zarychanski, Amarnath Pisipati, Aseem Kumar, Shravan Kethireddy, Eric J. Bow · 2018 · Mycology&#58 An International Journal on Fungal Biology
  2. Recommendations for the management of candidemia in adults in Latin America
    Márcio Nucci, Luis Thompson-Moya, Manuel Guzmán-Blanco, Iris Nora Tiraboschi, Jorge Alberto Cortés, Juan I. Echevarria, José Sifuentes‐Osornio, Jeannete Zurita, Marı́a Elena Santolaya, Tito Alvarado Matute et al. · 2013 · Revista Iberoamericana de Micología
  3. Insufficient Fluconazole Exposure in Pediatric Cancer Patients and the Need for Therapeutic Drug Monitoring in Critically Ill Children
    Kim C. M. van der Elst, Marieke Pereboom, Edwin R. van den Heuvel, Jos G. W. Kosterink, Elisabeth H. Schölvinck, Jan‐Willem C. Alffenaar · 2014 · Clinical Infectious Diseases
  4. Salivary Gland Dysfunction Secondary to Cancer Treatment
    Anette Vistoso Monreal, GREG POLONSKY, Caroline H. Shiboski, Vidya Sankar, Alessandro Villa · 2022 · Frontiers in Oral Health
  5. Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin
    Alessandra Oliva, Francesco Giuseppe De Rosa, Małgorzata Mikulska, Federico Pea, Maurizio Sanguinetti, Carlo Tascini, Mario Venditti · 2023 · Expert Review of Anti-infective Therapy
  6. Posaconazole: An Update of Its Clinical Use
    Simon Leung, Mara N. Poulakos, Jade D. Machin · 2015 · Pharmacy
  7. Therapeutic Drug Monitoring of Voriconazole in Children
    Jennifer Chen, Carol Chan, David Colantonio, Winnie Seto · 2011 · Therapeutic Drug Monitoring
  8. Nosocomial Candidemia; Risk Factors and Prognosis Revisited; 11 Years Experience from a Norwegian Secondary Hospital
    Jan‐Erik Berdal, Rolf Haagensen, Trond Egil Ranheim, Jørgen Vildershøj Bjørnholt · 2014 · PLoS ONE
  9. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
    Luis Eduardo López-Cortés, Benito Almirante, Manuel Cuenca‐Estrella, José Garnacho‐Montero, B. Padilla, Mireia Puig‐Asensio, Isabel Ruíz-Camps, Jesús Rodríguez‐Baño, B. Padilla, Patricia Muñóz et al. · 2016 · Clinical Microbiology and Infection
  10. Common Child and Adolescent Cutaneous Infestations and Fungal Infections
    Sherman J. Alter, Megan B. McDonald, Julie Schloemer, Ryan Q. Simon, Julian Trevino · 2018 · Current problems in pediatric and adolescent health care
  11. Risk factors and outcomes of patients with ocular involvement of candidemia
    Hyo‐Ju Son, Min Jae Kim, Suhwan Lee, Sungim Choi, Kyung Hwa Jung, Jiwon Jung, Yong Pil Chong, Sung‐Han Kim, Sang‐Ho Choi, Yang Soo Kim et al. · 2019 · PLoS ONE
  12. Miconazole mucoadhesive tablet for oropharyngeal candidiasis
    Rajesh V. Lalla, René‐Jean Bensadoun · 2010 · Expert Review of Anti-infective Therapy
  13. Miconazole Mucoadhesive Tablets: A Novel Delivery System
    J. A. Vazquez, J. D. Sobel · 2012 · Clinical Infectious Diseases
  14. Comparative Evaluation of the Vitek 2 Yeast Susceptibility Test and CLSI Broth Microdilution Reference Method for Testing Antifungal Susceptibility of Invasive Fungal Isolates in Italy: the GISIA3 Study
    Elisa Borghi, Roberta Iatta, Rita Sciota, Caterina Biassoni, Teresa Cuna, Maria Teresa Montagna, Giulia Morace · 2010 · Journal of Clinical Microbiology
  15. Antifungal activity of vitamin D3 against Candida albicans in vitro and in vivo
    Lei, Junwen, Xiao, Wei, Zhang, Jinping, Liu, Fangyan, Xin, Caiyan, Zhou, Bo, Chen, Wenbi, Song, Zhangyong · 2022 · Microbiological Research
  16. The assimilation of different carbon sources in <i>Candida albicans</i>: Fitness and pathogenicity
    Lok, Bronwyn, Adam, Mowaffaq Adam Ahmad, Kamal, Laina Zarisa Mohd, Chukwudi, Nwakpa Anthony, Sandai, Rosline, Sandai, Doblin · 2021 · Medical Mycology
  17. Systematic Analysis of the Lysine Acetylome in <i>Candida albicans</i>
    Zhou, Xiaowei, Qian, Guanyu, Yi, Xingling, Li, Xiaofang, Liu, Weida · 2016 · Journal of Proteome Research
  18. Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method
    Emilia Cantón, Javier Pemán, Carmen Íñiguez, David Hervás, José Luís López-Hontangas, Cidália Pina‐Vaz, Juan J. Camarena, María Isolina Campos-Herrero, Inmaculada García-García, Ana María García-Tapia et al. · 2013 · Journal of Clinical Microbiology
  19. Sepsis, severe sepsis, and septic shock: A review of the literature
    Keegan Tupchong, Alex Koyfman, Mark P. Foran · 2014 · African Journal of Emergency Medicine
  20. Impact of Targeted Antifungal Prophylaxis in Heart Transplant Recipients at High Risk for Early Invasive Fungal Infection
    Frédéric Tissot, Manuel A. Pascual, Roger Hullin, Patrick Yerly, Piergiorgio Tozzi, Pascal R. Meylan, Oriol Manuel · 2014 · Transplantation
  21. Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans
    Eman Salama Abdelmegeed, Mona I. Shaaban · 2013 · The Journal of Microbiology
  22. Glucose Directly Promotes Antifungal Resistance in the Fungal Pathogen, Candida spp.
    Santi M. Mandal, Denial Mahata, Ludovico Migliolo, Aditya Parekh, Partha Sarathi Addy, Mahitosh Mandal, Amit Basak · 2014 · Journal of Biological Chemistry
  23. Management of influenza infection in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)
    Francisco López‐Medrano, Elisa Cordero, Joan Gavaldà, Josep Maria Cruzado, María Ángeles Marcos, Pilar Pérez‐Romero, Núria Sabé, Miguel Ángel Gómez‐Bravo, Juan F. Delgado, Evelyn Cabral et al. · 2013 · Enfermedades Infecciosas y Microbiología Clínica
  24. Caspofungin-non-susceptible Candida isolates in cancer patients
    Diamantis P. Kofteridis, Russell Edward Lewis, Dimitrios P. Kontoyiannis · 2009 · Journal of Antimicrobial Chemotherapy
  25. Inpatient Ophthalmology Consultation for Fungemia: Prevalence of Ocular Involvement and Necessity of Funduscopic Screening
    Murtaza K. Adam, Sina Vahedi, Megan Nichols, Robert E. Fintelmann, Jeremy David Keenan, Sunir J. Garg, Jason Hsu, Joseph I. Maguire, Marc J. Spirn · 2015 · American Journal of Ophthalmology
  26. Invasive Fungal Infections
    Audrey N. Schuetz · 2013 · Clinics in Laboratory Medicine
  27. Comparison of BD Bactec Plus Aerobic/F Medium to VersaTREK Redox 1 Blood Culture Medium for Detection of Candida spp. in Seeded Blood Culture Specimens Containing Therapeutic Levels of Antifungal Agents
    Stefan F. Riedel, Stephen W. Eisinger, Lisa M. Dam, Paul D. Stamper, Karen C. Carroll · 2011 · Journal of Clinical Microbiology
  28. A Clinical Review of Echinocandins in Pediatric Patients
    Heather L. VandenBussche, Dean A. Van Loo · 2009 · Annals of Pharmacotherapy
  29. Fungal infections in the ICU
    Gennaro DE PASCALE, Mario Tumbarello · 2015 · Current Opinion in Critical Care
  30. T2 Magnetic Resonance for Fungal Diagnosis
    Fainareti N. Zervou, Ioannis M. Zacharioudakis, Jaclynn Kurpewski, Eleftherios E Mylonakis · 2016 · Methods in molecular biology
  31. A Linear 19-Mer Plant Defensin-Derived Peptide Acts Synergistically with Caspofungin against Candida albicans Biofilms
    Tanne L. Cools, Caroline Struyfs, Jan Wouter Drijfhout, Soňa Kucharíková, Celia Lobo Romero, Patrick Van Dijck, Marcelo Henrique Soller Ramada, Carlos Bloch, Bruno P.A. Cammue, Karin Thevissen · 2017 · Frontiers in Microbiology
  32. Candida catheter-related bloodstream infection in patients on home parenteral nutrition - Rates, risk factors, outcomes, and management
    Andrew Ian-Hong Phua, Kay Yee Hon, Andrew W. Holt, Margie O’Callaghan, Shailesh Bihari · 2019 · Clinical Nutrition ESPEN
  33. Epidemiological and clinico‐mycological profile of fungal wound infection from largest burn centre in Asia
    Malini Rajinder Capoor, Sonal Gupta, Sujata Sarabahi, Anshumali Mishra, Vinay Kumar Tiwari, Pushpa Aggarwal · 2011 · Mycoses
  34. How to treat fungal infections in ICU patients
    Dimitrios K. Matthaiou, Theodora C. Christodoulopoulou, George Dimοpoulos · 2015 · BMC Infectious Diseases
  35. Lactobacillus helveticus HY7801 ameliorates vulvovaginal candidiasis in mice by inhibiting fungal growth and NF-κB activation
    Hyun-Min Joo, Kyung‐Ah Kim, Kil-Sun Myoung, Young‐Tae Ahn, Jung-Hee Lee, Chul‐Sung Huh, Myung Joo Han, Dong‐Hyun Kim · 2012 · International Immunopharmacology
  36. Infectious Diseases in the Critically Ill Patients
    Steven J. Martin, Raymond J. Yost · 2011 · Journal of Pharmacy Practice
  37. Micafungin
    Lesley J. Scott · 2012 · Drugs
  38. Rapid redistribution of phosphatidylinositol-(4,5)-bisphosphate and septins during the Candida albicans response to caspofungin
    Badrane, Hassan, Nguyen, M. Hong, Blankenship, Jill R., Cheng, Shaoji, Hao, Binghua, Mitchell, Aaron P., Clancy, Cornelius J. · 2012 · Antimicrobial Agents and Chemotherapy
  39. Clinical Practice Patterns in Hospitalized Patients at Risk for Invasive Candidiasis
    Samuel L Aitken, Nicholas D. Beyda, Dhara N. Shah, Hannah R. Palmer, Todd Michael Lasco, Hoonmo L. Koo, Kevin W. Garey · 2014 · Annals of Pharmacotherapy
  40. ANTIFUNGAL SUSCEPTIBILITY TESTING: CURRENT ROLE FROM THE CLINICAL LABORATORY PERSPECTIVE
    Brunella Posteraro, Riccardo Torelli, Elena De Carolis, Patrizia Posteraro, Maurizio Sanguinetti · 2014 · Mediterranean Journal of Hematology and Infectious Diseases
  41. Update in Adult Urinary Tract Infection
    Lindsay E. Nicolle · 2011 · Current Infectious Disease Reports
  42. New antifungal antibiotics
    José Artur Paiva, José Manuel Pereira · 2013 · Current Opinion in Infectious Diseases
  43. Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability
    Curtis D. Collins, Cookinham, Smith · 2011 · Patient Preference and Adherence
  44. Usefulness of corticosteroid therapy during chronic disseminated candidiasis: case reports and literature review
    H. Chaussade, Frédéric Bastides, Séverine Lissandre, Pascale Blouin, E. Bailly, J. Chandenier, Emmanuel Gyan, Louis Bernard · 2012 · Journal of Antimicrobial Chemotherapy
  45. Emerging drugs and vaccines for Candidemia
    Brad Moriyama, Lori A. Gordon, Matthew William McCarthy, Stacey A. Henning, Thomas J. Walsh, Scott R Penzak · 2014 · Mycoses
  46. Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicansbloodstream infection
    Cintia Zoya Nunes, Alexandre Rodrigues Marra, Michael B. Edmond, Elivane da Silva Victor, Carlos Alberto Pires Pereira · 2013 · BMC Infectious Diseases
  47. Antifungal prophylaxis in liver transplant recipients: one size does not fit all
    Maddalena Giannella, Michele Bartoletti, Maria Cristina Morelli, Francesco Cristini, Sara Tedeschi, Caterina Campoli, Fabio Tumietto, Valentina Rosa Bertuzzo, Giorgio Ercolani, Stefano Faenza et al. · 2016 · Transplant Infectious Disease
  48. Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study
    David M. Jacobs, Thomas J. Dilworth, Nicholas D. Beyda, Anthony M. Casapao, Dana R. Bowers · 2017 · Antimicrobial Agents and Chemotherapy
  49. A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age
    Emmanuel Roilides, Fabianne Altruda de Moraes Costa Carlesse, Heidi K. Leister-Tebbe, Umberto Conte, Jean Li Yan, Ping Liu, Margaret Tawadrous, Jalal A. Aram, Flávio Queiroz‐Telles · 2018 · The Pediatric Infectious Disease Journal
  50. Intra‐abdominal infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
    Ghady Haidar, Michael Green, the American Society of Transplantation Infectious Diseases Community of Practice · 2019 · Clinical Transplantation
  51. Phytochemicals and Their Antifungal Potential against Pathogenic Yeasts
    Cristina de Andrade Monteiro, Julliana Ribeiro Alves dos Santos · 2019 · IntechOpen eBooks
  52. Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients
    Wei Zhang, Xingpeng Song, Hao Wu, Rui Zheng · 2020 · BMC Infectious Diseases
  53. Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users
    Santhanam Shanmughapriya, Haridevvenkatesan Sornakumari, Arumugam Lency, Senthil Kavitha, Kalimuthusamy Natarajaseenivasan · 2014 · Medical Mycology
  54. Fungal Infections in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation—Focus on Aspergillosis
    Márcio Nucci, Elias J. Anaissie · 2009 · Clinics in Chest Medicine
  55. The Gastrointestinal Complications of Oncologic Therapy
    Mehnaz Azra Shafi, Robert S. Bresalier · 2010 · Gastroenterology Clinics of North America
  56. Sensibilidad a fluconazol y voriconazol de especies de Candida aisladas de pacientes provenientes de unidades de cuidados intensivos en Medellín, Colombia (2001–2007)
    Alejandra Zuluaga, Catalina de Bedout Gómez, Carlos Andrés Agudelo Restrepo, Hans Hurtado Parra, Myrtha Arango Arteaga, Ángela Restrepo Moreno, Ángel González Marín · 2010 · Revista Iberoamericana de Micología
  57. Distribution and antifungal susceptibility ofCandidaspecies causing nosocomial candiduria
    Betil Özhak, Dilara Öğünç, Dilek Çolak, Gözde Öngüt, Levent Dönmez, Tümer Vural, Filiz Günseren · 2012 · Medical Mycology
  58. Fluconazole Resistance among Oral Candida Isolates from People Living with HIV/AIDS in a Nigerian Tertiary Hospital
    Iriagbonse I. Osaigbovo, Patrick Lofor, Rita Okeoghene Oladele · 2017 · Journal of Fungi
  59. Invasive candidiasis and candidemia: from current opinions to future perspectives
    Maria Rüping, Jörg Janne Vehreschild, Oliver A. Cornely · 2009 · Expert Opinion on Investigational Drugs
  60. Factors Associated with Esophageal Candidiasis and Its Endoscopic Severity in the Era of Antiretroviral Therapy
    So Nishimura, Naoyoshi Nagata, Takuro Shimbo, Naoki Asayama, Junichi Akiyama, Norio Ohmagari, Hirohisa Yazaki, Shinichi Oka, Naomi Uemura · 2013 · PLoS ONE
  61. European survey on the use of prophylactic fluconazole in neonatal intensive care units
    Florentia Kaguelidou, Chiara Pandolfini, Paolo Manzoni, Imti Choonara, Maurizio Rippa Bonati, Évelyne Jacqz-Aigrain · 2011 · European Journal of Pediatrics
  62. Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients
    Irma Hoyo, Gemma Sanclemente, Jorge Puig de la Bellacasa, Frederic Cofán, María José Ricart, M. Cardona, Jordi Colmenero, J. Fernández, Àngels Escorsell, Miquel Navasa et al. · 2014 · Transplant Infectious Disease
  63. Treatment and Prophylaxis of Invasive Candidiasis
    Nidhi Tripathi, Kevin Watt, Daniel K. Benjamin · 2012 · Seminars in Perinatology
  64. Comparative Efficacy of Echinocandins and Nonechinocandins for the Treatment of Candida parapsilosisInfections: AMeta‐analysis
    Pramodini B. Kale-Pradhan, Geoffrey Morgan, Sheila M. Wilhelm, Leonard B. Johnson · 2010 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  65. Invasive Fungal Infections in Children With Hematologic and Malignant Diseases
    Sevinç Nursev Özsevik, Gülnar Şensoy, Arzu Karlı, Canan Albayrak, Ayhan Dağdemir, Nurşen Belet, Murat Elli, Tunç Fışgın, Emel Özyürek, Feride Duru et al. · 2014 · Journal of Pediatric Hematology/Oncology
  66. Evidence-based Guidelines for Empirical Therapy of Neutropenic Fever in Korea
    Dong‐Gun Lee, Sung‐Han Kim, Soo Young Kim, Chung-Jong Kim, Chang‐Ki Min, Wan Beom Park, Yeon-Joon Park, Young Goo Song, Joung-Soon Jang, Jun Ho Jang et al. · 2011 · Infection and Chemotherapy
  67. Epidemiology of candidaemia in critically ill trauma patients: experiences of a level I trauma centre in North India
    Ranjit Singh, Immaculata Xess, Purva Mathur, Bijayini Behera, B. Gupta, MC Misra · 2010 · Journal of Medical Microbiology
  68. Effect of Denture-Related Stomatitis Fluconazole Treatment on Oral Candida albicans Susceptibility Profile and Genotypic Variability
    Maria Helena Figueiral, Patrícia Fonseca, Maria Lopes, Eugénia Pinto, Teresa Pereira-Leite, Benedita Sampaio‐Maia · 2015 · The Open Dentistry Journal
  69. FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy
    Sofia Costa‐de‐Oliveira, Isabel Marcos Miranda, Raquel Monteiro Silva, Ana P. Silva, Rita Rocha, António Amorim, Acácio Gonçalves Rodrigues, Cidália Pina‐Vaz · 2010 · Antimicrobial Agents and Chemotherapy
  70. Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients
    Andrea Cortegiani, Vincenzo Russotto, Francesca Ida Montalto, Grazia Foresta, Giuseppe Accurso, Cesira Palmeri, Santi Maurizio Raineri, Antonino Giarratano · 2014 · BMC Anesthesiology
  71. The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis
    Xiaofang Zhou, Ting Li, Shang­rong Fan, Yuxia Zhu, Xiaoping Liu, Xuedong Guo, Yiheng Liang · 2016 · Mycoses
  72. Recent developments in the management of invasive fungal infections in patients with oncohematological diseases
    Markus Ruhnke, Stefan Schwartz · 2016 · Therapeutic Advances in Hematology
  73. Flucytosine analogues obtained through Biginelli reaction as efficient combinative antifungal agents
    Mohmmad Younus Wani, Aijaz Ahmad, Santosh Kumar, ABÍLIO J. F. N. SOBRAL · 2017 · Microbial Pathogenesis
  74. Solasodine-3-O-β-d-glucopyranoside kills Candida albicans by disrupting the intracellular vacuole
    Wenqiang Chang, Ying Li, Ming Zhang, Sha Zheng, Yan Li, Hong‐Xiang Lou · 2017 · Food and Chemical Toxicology
  75. A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: A single‐center experience
    Bruna Lavezzo, Damiano Patrono, Francesco Tandoi, Silvia Martini, Fabrizio Fop, V. Carañana Ballerini, Chiara Stratta, Stefano Skurzak, Francesco Lupo, Paolo Strignano et al. · 2018 · Transplant Infectious Disease
  76. Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients
    Kevin J. Downes, Brian T. Fisher, Nicole R. Zane · 2020 · Pediatric Drugs
  77. Antifungal drugs: An updated review of central nervous system pharmacokinetics
    Fernanda Wirth, Kelly Ishida · 2020 · Mycoses
  78. A randomized clinical trial evaluating Photodithazine-mediated Antimicrobial Photodynamic Therapy as a treatment for Denture stomatitis
    Fernanda Alves, Juliana Cabrini Carmello, Gabriela Caroline Alonso, Ewerton Garcia de Oliveira Mima, Vanderlei Salvador Bagnato, Ana Cláudia Pavarina · 2020 · Photodiagnosis and Photodynamic Therapy
  79. Surveillance of Candida spp Bloodstream Infections: Epidemiological Trends and Risk Factors of Death in Two Mexican Tertiary Care Hospitals
    Dora Corzo-León, Tito Alvarado Matute, Arnaldo Lopes Colombo, Patricia Cornejo‐Juárez, Jorge Alberto Cortés, Juan I. Echevarria, Manuel Guzmán-Blanco, Alejandro Ernesto Macías, Márcio Nucci, Luis Ostrosky‐Zeichner et al. · 2014 · PLoS ONE
  80. Candidacerebral abscesses: a case report and review of the literature
    Andrea M. Fennelly, Amy K. Slenker, Lara Murphy Jones, Michael Moussouttas, Joseph A. DeSimone · 2013 · Medical Mycology
  81. Comparative Effects of Micafungin, Caspofungin, and Anidulafungin against a Difficult-To-Treat Fungal Opportunistic Pathogen, Candida glabrata
    Elisabetta Spreghini, Fiorenza Orlando, Maurizio Sanguinetti, Brunella Posteraro, Daniele Giannini, Esther Manso, Francesco Barchiesi · 2011 · Antimicrobial Agents and Chemotherapy
  82. The A395T Mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia
    Tan, Jingwen, Zhang, Jinqing, Chen, Wei, Sun, Yi, Wan, Zhe, Li, Ruoyu, Liu, Wei · 2015 · Mycopathologia
  83. Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases
    Kunlu Shen, Yu Gu, Yu Wang, Yajie Lu, Yueyan Ni, Huanhiuan Zhong, Yi Ping Shi, Xin Su · 2022 · Therapeutic Advances in Drug Safety
  84. Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients
    Nina Singh, Drew J. Winston, Ajit P. Limaye, Shawn J. Pelletier, Nasia Safdar, Michele Ileana Morris, Katherine G. Meneses, Ronald W. Busuttil, Marilyn M. Wagener, Lawrence Joseph Wheat · 2015 · Transplantation
  85. Advances in the treatment of invasive neonatal candidiasis
    Lorena Botero-Calderon, Daniel K Benjamin, Michael Cohen‐Wolkowiez · 2015 · Expert Opinion on Pharmacotherapy
  86. Variación de la epidemiología de las fungemias y de la sensibilidad al fluconazol de los aislamientos de hemocultivos en los últimos 10 años en España: resultados del estudio FUNGEMYCA
    Javier Pemán, Emilia Cantón, Juan J. Camarena, Julia Alcoba-Flórez, Julia Echeverría, David Navarro Ortega, José Martínez Alarcón, Dionisia Fontanals, Bárbara Gomila Sard, Buenaventura Buendía Moreno et al. · 2011 · Revista Iberoamericana de Micología
  87. Cost-Effectiveness Analysis of Multiplex PCR with Magnetic Resonance Detection versus Empiric or Blood Culture-Directed Therapy for Management of Suspected Candidemia
    Brandon S. Walker, Margaret V. Powers‐Fletcher, Robert L. Schmidt, Kimberly E. Hanson · 2016 · Journal of Clinical Microbiology
  88. Candida vertebral osteomyelitis (CVO) 28 cases from a 10-year retrospective study in France
    Clémence Richaud, Victoire DE LASTOURS, Xavière Panhard, David Petrover, B. Fantin, Agnès Lefort · 2017 · Medicine
  89. Chemical composition, antioxidant activity and antifungal effects of five Iranian essential oils against Candida strains isolated from urine samples
    Alireza Khosravi, Aghil Sharifzadeh, Donya Nikaein, Z. Almaie, Hassan Gandomi · 2018 · Journal de Mycologie Médicale
  90. Susceptibility ofCandida glabratabiofilms to echinocandins: alterations in the matrix composition
    Celia Fortuna Rodrigues, Maria Elisa Rodrigues, Mariana Henriques · 2018 · Biofouling
  91. Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients
    Arnaud Grégoire L’Huillier, Victor H. Ferreira, Terrance Ku, Ilona Bahinskaya, Deepali Kumar, Atul Humar · 2019 · American Journal of Transplantation
  92. The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years
    Masahiro Ishikane, Kayoko Hayakawa, Satoshi Kutsuna, Nozomi Takeshita, Norio Ohmagari · 2019 · PLoS ONE
  93. Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients
    J. M. Boonstra, Anne‐Grete Märtson, Indy Sandaradura, Jos G. W. Kosterink, Tjip S. van der Werf, Deborah J. E. Marriott, Jan G. Zijlstra, Daan Johannes Touw, Jan‐Willem C. Alffenaar · 2020 · Antimicrobial Agents and Chemotherapy
  94. Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years
    Selay Demirci‐Duarte, Sevtap Arıkan-Akdağlı, Dolunay Gülmez · 2021 · Mycoses
  95. Epidemiology and management of candidaemia - a retrospective, multicentre study in five hospitals in the UK
    Catriona Chalmers, S. Gaur, Jocelyn L.L. Chew, T. Wright, Anand Kumar, Sujeev Mathur, Wenyi Wan, I.M. Gould, Alistair Leanord, Abhijit M. Bal · 2011 · Mycoses
  96. Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection
    Alessandro Russo, Marco Falcone, Massimo Fantoni, Rita Murri, Luca Masucci, Paolo Carfagna, Maria Cristina Ghezzi, Brunella Posteraro, Maurizio Sanguinetti, Mario Venditti · 2015 · Clinical Microbiology and Infection
  97. Training should be the first step toward an antifungal stewardship program
    Maricela Valerio, Patricia Muñóz, Carmen Rodríguez, María Sanjurjo‐Sáez, Jesús Guinea, Emilio Bouza · 2014 · Enfermedades Infecciosas y Microbiología Clínica
  98. Effectiveness of Antibiotic-Lock Therapy for Long-term Catheter-Related Bacteremia Due to Gram-Negative Bacilli: A Prospective Observational Study
    G. Funalleras, Nuria Fernández‐Hidalgo, Antonio Borrego, Benito Almirante, Anna Maria Cardona Planes, Dolors Rodríguez-Pardo, Isabel Ruíz-Camps, Albert Pahissa · 2011 · Clinical Infectious Diseases
  99. Epidemiology, Risk Factors, and Therapy of Candidemia in Pediatric Hematological Patients
    Chiara Cugno, Simone Cesaro · 2012 · Pediatric Reports
  100. Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.
    Santiago Grau, Sònia Luque, Daniel Echeverría-Esnal, Luisa Sorlí, N. Campillo, M. Montero, Francisco Álvarez-Lerma, V. Plasencia, Juan Pablo Horcajada · 2016 · International Journal of Antimicrobial Agents